WEYERHAEUSER CO financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data WEYERHAEUSER CO files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	6,365	7,196	7,476	6,554	7,532	10,201	10,184	7,674	7,124	6,905
Cost of revenue	4,980	5,298	5,592	5,412	5,447	6,103	6,564	5,992	5,811	5,880
Gross profit	1,385	1,898	1,884	1,142	2,085	4,098	3,620	1,682	1,313	1,025
Research and development	19	14	8	6	5	5	6	7	7	5
General and administrative	338	310	318	348	347	396	398	431	480	453
Operating income	822	1,131	1,394	651	1,710	3,643	3,080	1,186	685	731
Interest expense	431	393	375	378	351	313	270	280	269	273
Other non-operating income			-52	-28	-35	-25	-24	-30	-15
Pre-tax income	504	716	807	-213	982	3,316	2,305	937	427	260
Income tax	89	134	59	-137	185	709	425	98	31	-64
Net income	1,027	582	748	-76	797	2,607	1,880	839	396	324
EBITDA	1,387	1,652	1,880	1,161	2,182	4,120	3,560	1,686	1,187	1,240
EPS, basic	1.40	0.77	0.99	-0.10	1.07	3.48	2.53	1.15	0.54	0.45
EPS, diluted	1.39	0.77	0.99	-0.10	1.07	3.47	2.53	1.15	0.54	0.45
Shares, basic (weighted)	719	753	755	746	747	749	742	732	728	723
Shares, diluted (weighted)	722	757	757	746	748	751	743	732	729	724
Dividend per share	1.24	1.25	1.32	1.36	0.51	1.18	2.17	1.66	0.94	0.84

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	676	824	334	139	495	1,879	1,581	1,164	684	464
Short-term investments							0
Receivables	390	396	337	309	450	507	357	354	306	303
Inventory	358	383	389	416	443	520	550	566	607	593
Other current assets	114	98	152	147	139	205	216	219	142	154
Total current assets	1,622	1,715	1,602	1,611	1,609	3,135	2,746	2,313	1,748	1,652
Property, plant and equipment	1,562	1,618	1,857	1,969	2,013	2,057	2,171	2,269	2,329	2,420
Lease right-of-use assets				120	106	101	102	105	138	125
Goodwill	40	40
Other non-current assets	224	356	312	414	401	503	375	388	408	397
Total assets	19,243	18,059	17,249	16,406	16,311	17,652	17,340	16,983	16,536	16,613
Accounts payable	233	249	222	246	204	281	247	287	255	278
Accrued liabilities	692	645	490	530	596	673	511	501	512	478
Deferred revenue	40	48
Short-term debt	281	62	500	0	150	0	978	0	210	522
Total current liabilities	1,206	1,165	1,939	1,006	950	954	1,740	788	977	1,278
Long-term debt	6,329	5,930	5,419	6,147	5,325	5,099	4,071	5,069	4,866	5,050
Lease liabilities				103	95	90	91	96	121	108
Other non-current liabilities	269	276	275	377	370	346	340	348	350	356
Total liabilities	10,063	9,160	8,203	8,229	7,580	6,885	6,591	6,747	6,815	7,187
Total debt	6,610	5,992	5,919	6,147	5,475	5,099	5,053	5,069	5,076	5,572
Paid-in capital	8,282	8,439	8,172	8,152	8,208	8,181	7,691	7,608	7,500	7,390
Retained earnings	1,421	1,078	1,093	-3	411	2,131	2,389	2,009	1,715	1,428
Other comprehensive income	-1,459	-1,562	-1,152	-904	-822	-479	-247	-293	-402	-293
Shareholders' equity			9,046	8,177	8,731	10,767	10,749	10,236	9,721	9,426
Total equity	9,180	8,899	9,046	8,177	8,731	10,767	10,749	10,236	9,721	9,426
Total liabilities and equity	19,243	18,059	17,249	16,406	16,311	17,652	17,340	16,983	16,536	16,613
Shares outstanding	749	755	746	745	747	747	733	730	726	721

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	1,027	582	748	-76	797	2,607	1,880	839	396	324
Depreciation and amortization	565	521	486	510	472	477	480	500	502	509
Stock-based compensation	60	40	42	30	30	30	33	36	43	43
Deferred income tax	76	42	72	-169	-56	14	-30	-4	-40	-114
Change in receivables	-54	-35	62	13	-141	-57	149	4	45	14
Change in inventory	61	-39	-14	-23	-25	-77	-37	-13	-55	0
Change in payables	11	106	-154	37	-17	113	-111	35	-38	11
Cash from operations	735	1,201	1,112	966	1,529	3,159	2,832	1,433	1,008	562
Capital expenditures	-451	-358	-368	-57	-56	-55	-53	-57	-52	-51
Cash from investing	2,559	367	-440	187	185	-325	-759	-508	-636	-475
Debt issued	1,698	225	0	739	732	0	881	992	0	1,199
Debt repaid	-2,423	-831	-62
Stock issued	61	128	52	13	33	51	16
Share buybacks	-2,003	0	-366	-60	0	-100	-543	-131	-154	-160
Dividends paid	-932	-941	-995	-1,013	-381	-884	-1,617	-1,216	-684	-606
Cash from financing	-3,630	-1,420	-1,162	-1,348	-1,358	-1,330	-2,491	-1,342	-852	-290
Net change in cash	-336	148	-490	-195	356	1,504	-418	-417	-480	-203
Free cash flow	284	843	744	909	1,473	3,104	2,779	1,376	956	511
Interest paid	446	381	358	370	365	315	283	283	259	272
Income taxes paid	485	169	95	-2	176	609	566	63	60	67

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $20.01 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	14.5%	Gross profit / revenue.
Operating margin	12.3%	Operating income / revenue.
EBITDA margin	19.8%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	5.5%	Pre-tax income / revenue.
Net margin	6.9%	Net income / revenue.
FCF margin	7.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	8.0%	Cash from operations / revenue.
Effective tax rate	-24.2%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	5.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	2.9%	Net income / average total assets.
Return on invested capital (ROIC)	4.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	0.1%	Research and development expense / revenue.
Stock-based pay / revenue	0.6%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.8%	Capital expenditures / revenue.
D&A / revenue	7.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-3.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-12.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-1.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-21.9%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-34.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-13.2%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	6.7%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-38.1%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-15.6%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	4.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-29.6%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-10.7%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-18.2%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-44.4%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-16.5%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-16.7%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-43.8%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-15.9%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-44.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-41.7%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-18.1%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-46.5%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-43.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-19.1%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	-10.6%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	-27.1%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	10.5%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-3.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-4.3%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	1.5%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	0.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-1.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	0.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.9%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.7%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.82x	Current assets / current liabilities.
Quick ratio	1.00x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.58x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.56x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	32.1%	Total debt / total assets.
Liabilities / assets	42.7%	Total liabilities / total assets.
Net debt	$4.78B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	3.53x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	3.09x	Operating income / interest expense.
Working capital	$735.0M	Current assets - current liabilities.
Tangible book value	$9.46B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.41x	Revenue / average total assets.
Fixed asset turnover	2.85x	Revenue / average property, plant and equipment.
Inventory turnover	9.70x	Cost of revenue / average inventory.
Days inventory	38 days	365 x average inventory / cost of revenue.
Receivables turnover	18.4x	Revenue / average receivables.
Days sales outstanding	20 days	365 x average receivables / revenue.
Days payables	19 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	38 days	Days inventory + days sales outstanding - days payables.
FCF conversion	104.9%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	9.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.65	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$9.49	Revenue / diluted weighted shares.
FCF per share	$0.69	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.76	Cash from operations / diluted weighted shares.
Book value per share	$13.12	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$13.12	Tangible book value / shares outstanding.
Cash per share	$0.73	(Cash + short-term investments) / shares outstanding.
Payout ratio	128.2%	Dividends paid / net income, when net income is positive.
Dividends / FCF	122.2%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	11.1%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$14.42B	Share price x shares outstanding.
Enterprise value	$19.20B	Market cap + total debt - cash - short-term investments.
P/E	30.6x	Market cap / net income. Only when net income is positive.
P/S	2.10x	Market cap / revenue.
P/B	1.53x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.53x	Market cap / tangible book value, when positive.
P/FCF	29.1x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	26.4x	Market cap / cash from operations, when positive.
EV/Sales	2.80x	Enterprise value / revenue.
EV/EBIT	22.7x	Enterprise value / operating income, when both are positive.
EV/EBITDA	14.2x	Enterprise value / EBITDA, when both are positive.
EV/FCF	38.8x	Enterprise value / free cash flow, when both are positive.
FCF yield	3.4%	Free cash flow / market cap.
Earnings yield	3.3%	Net income / market cap (the inverse of P/E).
Dividend yield	4.2%	Dividends paid over the period / market cap.
Shareholder yield	4.6%	(Dividends paid + share buybacks) / market cap.

What was WEYERHAEUSER CO's revenue in fiscal 2025?

WEYERHAEUSER CO reported revenue of $6.91B for fiscal 2025, 3.1% lower than the year before.

Was WEYERHAEUSER CO profitable in fiscal 2025?

Yes. Net income was $324.0M, a net margin of 4.7%.

How much free cash flow did WEYERHAEUSER CO generate in fiscal 2025?

Cash from operations of $562.0M minus capital expenditures of $51.0M left free cash flow of $511.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to WEYERHAEUSER CO